HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of a new primary human pancreatic tumor line.

Abstract
A primary human pancreatic tumor line (BxPC-3) has been established from a biopsy specimen of a histologically confirmed adenocarcinoma of the body of the pancreas. Tumorigenicity was proven by xenograft in athymic nude mice. Upon re-establishment of tumor xenografts in tissue culture, the epithelial tumor cells retained their original morphology. Histopathologically, the tumors grown in nude mice exhibited the original characteristics of the primary adenocarcinoma in the patient, producing traceable mucin and displaying moderately well to poorly differentiated adenocarcinomas with occasional lymphocytic infiltrations at the tumor peripheries. Furthermore, the tumor xenografts differentially expressed carcinoembryonic antigen, human pancreas cancer-associated antigen, and human pancreas-specific antigen. Karyotyping and glucose-6-phosphate dehydrogenase isoenzyme characterization revealed that this tumor line was of human origin and devoid of HeLa cell contamination. The BxPC-3 tumor line has been maintained for more than four years in our laboratory and represents a valuable model for primary human pancreatic cancer.
AuthorsM H Tan, N J Nowak, R Loor, H Ochi, A A Sandberg, C Lopez, J W Pickren, R Berjian, H O Douglass Jr, T M Chu
JournalCancer investigation (Cancer Invest) Vol. 4 Issue 1 Pg. 15-23 ( 1986) ISSN: 0735-7907 [Print] England
PMID3754176 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Adenocarcinoma (genetics, pathology)
  • Animals
  • Biopsy
  • Cell Line
  • Chromosome Banding
  • Culture Techniques (methods)
  • Humans
  • Karyotyping
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Pancreatic Neoplasms (genetics, pathology)
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: